Sanner Opens its First US Production Facility in North Carolina
Sanner, a provider of high-quality healthcare packaging and drug delivery solutions, officially opened its first US-based production facility in Greensboro, North Carolina. This marks a significant point in the company’s 134-year history, introducing localized production to better serve MedTech and pharmaceutical partners across North America.
“This is more than just a new facility,” said Christian Classen, CSO of Sanner Group. “It’s a bold step forward in our global journey, reinforcing our long-term commitment to supporting our customers in North America with local production, cutting-edge technology, and world-class service.”
Sanner’s investment in Greensboro expands its role as a supplier of primary packaging and as a Contract Development and Manufacturing Organization (CDMO) for the healthcare industry, combining global quality standards with local operations. Sanner provides manufacturing and contract development services for drug delivery devices, diagnostics, connected health devices, and pharmaceutical packaging.
The 60,500 sq. ft. site includes GMP-certified cleanrooms (ISO class 7 and 8), advanced injection molding, high-speed desiccant filling, and state-of-the-art laboratory facilities. The facility is designed for future growth, with 20,000 sq. ft. of expansion space included in the site.
“We’re grateful for the warm welcome and outstanding support from the Greensboro community,” added Classen. “This new site is a testament to what’s possible when global vision meets local partnership. Today, Sanner opens the door to a new chapter: this time, in the US”
With recent expansions in Germany, China, and now the United States, Sanner is well-positioned to support the evolving needs of global healthcare customers to bring innovative solutions closer to where they’re needed most.
most read
Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
Novo Nordisk's CEO Lars Fruergaard Jørgensen Steps Down
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Supply Chain and Logistics Trends in the Chemical Industry
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Oxea Returns to its Roots
Oxea is returning to its old name and its roots.
Valerie Diele-Braun Leaves IMCD
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.